Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: Initial evaluation
Michael Vinzenz Knopp, Helge G. Bischoff, Ante Rimac et al. · Nuclear Medicine and Biology · 1996
Cited by 41 works. doi:10.1016/0969-8051(96)00085-6
Authors
References
- Pathologic Basis of Disease.
- Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
- A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
- Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
- Hematopoietic growth factors.
- Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
- Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
- Hematopoietic Growth Factors
- Metabolic imaging of human extremity musculoskeletal tumors by PET.